Previous 10 | Next 10 |
Tyme Technologies (NASDAQ: TYME ): FY Non-GAAP EPS of -$0.17 beats by $0.04 ; GAAP EPS of -$0.19. More news on: Tyme Technologies, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
TYME-88-Panc pivotal trial enrolling patients using oral SM-88 as a potential treatment for third-line pancreatic cancer PanCAN enrolling patients in its Precision Promise SM adaptive randomized Phase II/III registration-intent trial evaluating oral SM-88 as second-line monotherapy fo...
Tyme Technologies, Inc. (NASDAQ:TYME) , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that leadership will participate at the Jefferies Virtual Healthcare Conference on Wednesday, June 3, 2020. The Company will present its corporate...
The study shows that for every additional $1 spent on innovative medicines for pancreatic cancer in 2016, there was a reduction in non-medicine spending of $8 to $9 This preliminary study reported that total medical spend is markedly reduced when budgets are funded towards better pharm...
Preclinical data suggests multiple mechanisms of action for SM-88, including an increase in reactive oxygen species, alterations in autophagy and immunomodulation Preclinical data for TYME-18, an intra-tumoral delivered therapy, displayed statistically significant anti-cancer effects i...
Tyme Technologies, Inc. (NASDAQ:TYME) , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that the Company will host a conference call and live webcast on Wednesday, May 20, 2020 at 5:00 P.M. ET to report its financial and operating res...
Chesapeake Energy (NYSE: CHK ) -43% after preparing bankruptcy filing. More news on: Chesapeake Energy Corporation, On Deck Capital, Inc., Capricor Therapeutics, Inc., Stocks on the move, , Read more ...
Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that management will present at the 2020 Cross-Border Healthcare Webinar Series on Tuesday, April 7, 2020. The Company will present its corporate...
Tyme Technologies ( TYME ) had a noteworthy 2019 with several major milestones to add to the bullish case. What is more, Tyme has multiple catalysts scheduled in the first and second half of 2020, which will only add to that bullish case. Despite the recent and pending milestones, the share pr...
Strategic collaboration with Eagle Pharmaceuticals entitles TYME to receive up to a total of $40 million, which included $20 million upfront already received and $20 million in potential milestone payments. TYME-88-Panc pivotal trial started enrollment using oral SM-88 as a potential trea...
News, Short Squeeze, Breakout and More Instantly...
Tyme Technologies Inc. Company Name:
TYME Stock Symbol:
NASDAQ Market:
Tyme Technologies Inc. Website:
-- Combined Company to Trade on Nasdaq Under Ticker “SYRS” -- -- Syros Announces 1-for-10 Reverse Stock Split of Common Stock -- Syros Pharmaceuticals, Inc. (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, and ...
BEDMINSTER, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME) (“Tyme” or the “Company”), today announced that independent proxy advisory firms Glass, Lewis & Co. (“Glass Lewis”) and Institutional Shareholder Services...
Penny stocks are shares of companies trading for less than $5 and have offered speculative potential during the stock market crash this year. They’re known for their high-risk and high reward, and when it comes to a choppy stock market, as we’ve seen recently, traders seek...